Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

NCT07735117 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome
DRUG: Cytarabine
DRUG: Granulocyte Colony-Stimulating Factor(G-CSF)
DRUG: Venetoclax
DRUG: Venetoclax
DRUG: azacitidine

Sponsor

Ruijin Hospital

Collaborators

[object Object]